The problem is no revenue stream..They tested 5 diseases and only succeeded with Bronchitis which every physician can tell by visual inspection (atleast 90% of the time).... without FDA approval it's just going to chew cash reserve and FDA is atleast 12 months away based on previous experience - Sorry previous trials were failure so don't consider that...Every thing has to go right to get there --
- Forums
- ASX - By Stock
- Ann: Dr Philip Currie Joins ResApp's Scientific Advisory Board
The problem is no revenue stream..They tested 5 diseases and...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries